{"id":"W2761878534","doi":"10.1056/nejmoa1614598","title":"Obinutuzumab for the First-Line Treatment of Follicular Lymphoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":788,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre","funders":"Cancer Research UK","keywords":"Obinutuzumab; Rituximab; Medicine; Follicular lymphoma; Internal medicine; Oncology; Chemotherapy; Hazard ratio; Adverse effect; Lymphoma; CD20; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003609657,0.0001814091,0.0007151966,0.0000801463,0.0002168327,0.00001428416,0.0001900728,0.00005665961,0.00007687376],"category_scores_gemma":[0.0003851593,0.00007721076,0.0002825065,0.00003924566,0.0001539821,0.00005864074,0.00001534986,0.00003630057,0.000002025319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003038465,"about_ca_system_score_gemma":0.0003556133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005778165,"about_ca_topic_score_gemma":0.0001043995,"domain_scores_codex":[0.9987753,0.00001653015,0.000534349,0.000118177,0.0003766583,0.0001790012],"domain_scores_gemma":[0.9978428,0.0004790056,0.0006935156,0.0005179212,0.0002530381,0.0002137104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00325337,0.0007048129,0.03076808,0.00006730865,0.001519495,0.0004790231,0.001116509,0.0000428158,0.0003003115,0.0004205474,0.009734675,0.951593],"study_design_scores_gemma":[0.2641046,0.01699851,0.1344731,0.0006780894,0.002645508,0.001727581,0.0001165923,0.0001905909,0.005907061,0.0005700781,0.5724913,0.00009693876],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9020374,0.02006665,0.0007213542,0.07359252,0.0014156,0.0008948157,0.00001366261,0.000009613645,0.00124838],"genre_scores_gemma":[0.989033,0.005355293,0.0004073258,0.0003003803,0.00421994,0.00001399668,0.000005050637,0.00001618709,0.0006487964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9514961,"threshold_uncertainty_score":0.3148564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04278529139120291,"score_gpt":0.3180883775896582,"score_spread":0.2753030861984553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}